Company profile RVNC
After 38 days of this quarter the interest is at 50.0. Based on that we can calculate that during remaining 53 days it will total up to 120.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 118 | 75 -36.4% QoQ | 74 -1.3% QoQ | 141 90.5% QoQ |
| 2020 | 108 -8.5% YoY -23.4% QoQ | 166 121.3% YoY 53.7% QoQ | 148 100.0% YoY -10.8% QoQ | 184 30.5% YoY 24.3% QoQ |
| 2021 | 78 -27.8% YoY -57.6% QoQ | 19 -88.6% YoY -75.6% QoQ | 77 -48.0% YoY 305.3% QoQ | 201 9.2% YoY 161.0% QoQ |
| 2022 | 42 -46.2% YoY -79.1% QoQ | 116 510.5% YoY 176.2% QoQ | 213 176.6% YoY 83.6% QoQ | 199 -1.0% YoY -6.6% QoQ |
| 2023 | 99 135.7% YoY -50.3% QoQ | 167 44.0% YoY 68.7% QoQ | 126 -40.8% YoY -24.6% QoQ | 86 -56.8% YoY -31.7% QoQ |
| 2024 | 50 -49.5% YoY -41.9% QoQ | - | - | - |
The average 5 years interest of Revance Therapeutics stock was 9.57 per week. The last year interest of Revance Therapeutics stock compared to the last 5 years has changed by -0.52%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 6.49%.
There is not enough data for Revance Therapeutics login to provide analysis
There is not enough data for Revance Therapeutics login to provide correlation calculation
There is not enough data for Revance Therapeutics login to provide analysis
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. Revance Therapeutics news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 109 | 100 -8.3% QoQ | 362 262.0% QoQ | 61 -83.1% QoQ |
| 2020 | 135 23.9% YoY 121.3% QoQ | 96 -4.0% YoY -28.9% QoQ | 36 -90.1% YoY -62.5% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 155 14.8% YoY inf% QoQ | 109 13.5% YoY -29.7% QoQ | 313 769.4% YoY 187.2% QoQ | 121 inf% YoY -61.3% QoQ |
| 2022 | 235 51.6% YoY 94.2% QoQ | 137 25.7% YoY -41.7% QoQ | 194 -38.0% YoY 41.6% QoQ | 96 -20.7% YoY -50.5% QoQ |
| 2023 | 146 -37.9% YoY 52.1% QoQ | 158 15.3% YoY 8.2% QoQ | 121 -37.6% YoY -23.4% QoQ | 67 -30.2% YoY -44.6% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Revance Therapeutics news was 10.58 per week. The last year interest of Revance Therapeutics news compared to the last 5 years has changed by -24.57%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -34.32%.
There is not enough data for Revance Therapeutics careers to provide analysis
There is not enough data for Revance Therapeutics careers to provide correlation calculation
There is not enough data for Revance Therapeutics careers to provide analysis
There is not enough data for Revance Therapeutics products to provide analysis
There is not enough data for Revance Therapeutics products to provide correlation calculation
There is not enough data for Revance Therapeutics products to provide analysis
There is not enough data for Revance Therapeutics website to provide analysis
There is not enough data for Revance Therapeutics website to provide correlation calculation
There is not enough data for Revance Therapeutics website to provide analysis
There is not enough data for Revance Therapeutics contact to provide analysis
There is not enough data for Revance Therapeutics contact to provide correlation calculation
There is not enough data for Revance Therapeutics contact to provide analysis
There is not enough data for Revance Therapeutics financials to provide analysis
There is not enough data for Revance Therapeutics financials to provide correlation calculation
There is not enough data for Revance Therapeutics financials to provide analysis
There is not enough data for Revance Therapeutics analysis to provide analysis
There is not enough data for Revance Therapeutics analysis to provide correlation calculation
There is not enough data for Revance Therapeutics analysis to provide analysis
Google Trends for Revance Therapeutics investor relations
Not enough data for reliable calculations!
There is not enough data for Revance Therapeutics investor relations to provide analysis
There is not enough data for Revance Therapeutics investor relations to provide correlation calculation
There is not enough data for Revance Therapeutics investor relations to provide analysis